Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

A surgical technique using tissue derived from donated placentas has been linked to faster erectile recovery after prostate ...

Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...

Profound Medical (NASDAQ:PROF) and Telix Pharmaceuticals (NASDAQ:TLX) have signed a co-education agreement aimed at increasing physician awareness of how advanced diagnostic imaging can support ...

Thousands of men with prostate cancer could avoid the debilitating urinary and sexual side effects of surgery, thanks to a ...

Panelists discuss how sharing personal experiences with diagnosis helps illuminate the critical questions patients should ask their care teams and the pivotal role oncologists play in guiding ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

The Prostate Cancer Foundation (PCF) today announced the publication of a new consensus framework designed to help clinicians ...

Prostate cancer cases are rising in India, but advances in diagnostics, targeted therapies and personalised treatment are ...

The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.